Advertisement
Original Report| Volume 18, ISSUE 10, P1216-1228, October 2017

Download started.

Ok

Psychological Characteristics and Pain Frequency Are Associated With Experimental Pain Sensitivity in Pediatric Patients With Sickle Cell Disease

  • Nitya Bakshi
    Affiliations
    Division of Pediatric Hematology-Oncology-Bone Marrow Transplantation, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania

    Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
    Search for articles by this author
  • Ines Lukombo
    Affiliations
    Division of Pediatric Hematology-Oncology-Bone Marrow Transplantation, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
    Search for articles by this author
  • Helen Shnol
    Affiliations
    Department of Anesthesiology, University of Pittsburgh, Pittsburgh, Pennsylvania
    Search for articles by this author
  • Inna Belfer
    Affiliations
    Department of Anesthesiology, University of Pittsburgh, Pittsburgh, Pennsylvania
    Search for articles by this author
  • Lakshmanan Krishnamurti
    Correspondence
    Address reprint requests to Lakshmanan Krishnamurti, MD, Emory University, Division of Pediatric Hematology/Oncology/BMT, Department of Pediatrics, Emory University, 2015 Uppergate Drive, Atlanta, GA; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA 30322.
    Affiliations
    Division of Pediatric Hematology-Oncology-Bone Marrow Transplantation, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania

    Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
    Search for articles by this author

      Highlights

      • Pain sensitivity in sickle cell disease (SCD) is influenced by psychological factors.
      • Frequency of pain episodes also influences pain sensitivity in SCD.
      • Age- and gender-based normative data on pain sensitivity should be used to define impaired pain sensitivity in SCD.

      Abstract

      Sickle cell disease (SCD) is associated with episodes of severe vaso-occlusive pain beginning in infancy with a subset of patients with SCD transitioning to chronic pain. Response to experimental pain using quantitative sensory testing in these patients suggests altered pain processing. The objectives of this study were to characterize sensitivity to multiple modalities of experimental pain stimuli and to interrogate the relationship of psychological covariates, clinical pain burden, and pain-related outcomes to experimental pain sensitivity in children with SCD compared with healthy individuals of similar age and sex. Cross-sectional assessments of psychological characteristics were performed, and quantitative sensory testing methods were used to measure experimental pain sensitivity in children age 8 to 21 years. Anxiety, depressive symptoms, catastrophizing, and somatization were found to be associated with increased sensitivity to experimental pain stimuli. Increased frequency of painful episodes in SCD was associated with decreased sensitivity to heat pain and decreased mechanical temporal summation. These data suggest that careful consideration be given to psychological factors, age, sex, and clinical burden of pain when studying response to experimental pain in SCD.

      Perspective

      In this study of patients with SCD, a condition associated with recurrent acute or chronic pain, psychological factors such as depression, anxiety, and catastrophizing are associated with increased sensitivity to experimental pain stimuli. Further study is need to delineate the role of these factors in chronic SCD pain.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bar-Shalita T.
        • Vatine J.J.
        • Seltzer Z.
        • Parush S.
        Psychophysical correlates in children with sensory modulation disorder (SMD).
        Physiol Behav. 2009; 98: 631-639
        • Baumgartner U.
        • Magerl W.
        • Klein T.
        • Hopf H.C.
        • Treede R.D.
        Neurogenic hyperalgesia versus painful hypoalgesia: Two distinct mechanisms of neuropathic pain.
        Pain. 2002; 96: 141-151
        • Belfer I.
        Nature and nurture of human pain.
        Scientifica (Cairo). 2013; 2013: 415279
        • Blankenburg M.
        • Boekens H.
        • Hechler T.
        • Maier C.
        • Krumova E.
        • Scherens A.
        • Magerl W.
        • Aksu F.
        • Zernikow B.
        Reference values for quantitative sensory testing in children and adolescents: Developmental and gender differences of somatosensory perception.
        Pain. 2010; 149: 76-88
        • Blankenburg M.
        • Meyer D.
        • Hirschfeld G.
        • Kraemer N.
        • Hechler T.
        • Aksu F.
        • Krumova E.K.
        • Magerl W.
        • Maier C.
        • Zernikow B.
        Developmental and sex differences in somatosensory perception–a systematic comparison of 7- versus 14-year-olds using quantitative sensory testing.
        Pain. 2011; 152: 2625-2631
        • Brandow A.M.
        • Farley R.A.
        • Dasgupta M.
        • Hoffmann R.G.
        • Panepinto J.A.
        The use of neuropathic pain drugs in children with sickle cell disease is associated with older age, female sex, and longer length of hospital stay.
        J Pediatr Hematol Oncol. 2015; 37: 10-15
        • Brandow A.M.
        • Panepinto J.A.
        Clinical interpretation of quantitative sensory testing as a measure of pain sensitivity in patients with sickle cell disease.
        J Pediatr Hematol Oncol. 2016; 38: 288-293
        • Brandow A.M.
        • Stucky C.L.
        • Hillery C.A.
        • Hoffmann R.G.
        • Panepinto J.A.
        Patients with sickle cell disease have increased sensitivity to cold and heat.
        Am J Hematol. 2013; 88: 37-43
        • Cain D.M.
        • Vang D.
        • Simone D.A.
        • Hebbel R.P.
        • Gupta K.
        Mouse models for studying pain in sickle disease: Effects of strain, age, and acuteness.
        Br J Haematol. 2012; 156: 535-544
        • Campbell C.M.
        • Carroll C.P.
        • Kiley K.
        • Han D.
        • Haywood Jr., C.
        • Lanzkron S.
        • Swedberg L.
        • Edwards R.R.
        • Page G.G.
        • Haythornthwaite J.A.
        Quantitative sensory testing and pain-evoked cytokine reactivity: Comparison of patients with sickle cell disease to healthy matched controls.
        Pain. 2016; 157: 949-956
        • Campbell C.M.
        • Moscou-Jackson G.
        • Carroll C.P.
        • Kiley K.
        • Haywood Jr., C.
        • Lanzkron S.
        • Hand M.
        • Edwards R.R.
        • Haythornthwaite J.A.
        An evaluation of central sensitization in patients with sickle cell disease.
        J Pain. 2016; 17: 617-627
        • Cataldo G.
        • Rajput S.
        • Gupta K.
        • Simone D.A.
        Sensitization of nociceptive spinal neurons contributes to pain in a transgenic model of sickle cell disease.
        Pain. 2015; 156: 722-730
        • Cella D.
        • Yount S.
        • Rothrock N.
        • Gershon R.
        • Cook K.
        • Reeve B.
        • Ader D.
        • Fries J.F.
        • Bruce B.
        • Rose M.
        The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years.
        Med Care. 2007; 45: S3-S11
        • Chan K.S.
        • Mangione-Smith R.
        • Burwinkle T.M.
        • Rosen M.
        • Varni J.W.
        The PedsQL: Reliability and validity of the short-form generic core scales and Asthma Module.
        Med Care. 2005; 43: 256-265
        • Chen X.
        • Origasa H.
        • Ichida F.
        • Kamibeppu K.
        • Varni J.W.
        Reliability and validity of the Pediatric Quality of Life Inventory (PedsQL) Short Form 15 Generic Core Scales in Japan.
        Qual Life Res. 2007; 16: 1239-1249
        • Citero Vde A.
        • Levenson J.L.
        • McClish D.K.
        • Bovbjerg V.E.
        • Cole P.L.
        • Dahman B.A.
        • Penberthy L.T.
        • Aisiku I.P.
        • Roseff S.D.
        Smith WR: The role of catastrophizing in sickle cell disease–the PiSCES project.
        Pain. 2007; 133: 39-46
      1. IASP Taxonomy Working Group: Classification of Chronic Pain, Second Edition (Revised). Classification of chronic pain (introduction) Available at: https://www.iasp-pain.org/files/Content/ContentFolders/Publications2/ClassificationofChronicPain/Introduction.pdf. Accessed October 19, 2016

        • Crombez G.
        • Bijttebier P.
        • Eccleston C.
        • Mascagni T.
        • Mertens G.
        • Goubert L.
        • Verstraeten K.
        The child version of the pain catastrophizing scale (PCS-C): A preliminary validation.
        Pain. 2003; 104: 639-646
        • Dampier C.
        • Barry V.
        • Gross H.E.
        • Lui Y.
        • Thornburg C.D.
        • DeWalt D.A.
        • Reeve B.B.
        Initial evaluation of the pediatric PROMIS® health domains in children and adolescents with sickle cell disease.
        Pediatr Blood Cancer. 2016; 63: 1031-1037
        • Edwards R.R.
        • Smith M.T.
        • Stonerock G.
        • Haythornthwaite J.A.
        Pain-related catastrophizing in healthy women is associated with greater temporal summation of and reduced habituation to thermal pain.
        Clin J Pain. 2006; 22: 730-737
        • Ezenwa M.O.
        • Molokie R.E.
        • Wang Z.J.
        • Yao Y.
        • Suarez M.L.
        • Pullum C.
        • Schlaeger J.M.
        • Fillingim R.B.
        • Wilkie D.J.
        Safety and utility of quantitative sensory testing among adults with sickle cell disease: Indicators of neuropathic pain?.
        Pain Pract. 2016; 16: 282-293
        • Fillingim R.B.
        • King C.D.
        • Ribeiro-Dasilva M.C.
        • Rahim-Williams B.
        • Riley 3rd, J.L.
        Sex, gender, and pain: A review of recent clinical and experimental findings.
        J Pain. 2009; 10: 447-485
        • Garrison S.R.
        • Kramer A.A.
        • Gerges N.Z.
        • Hillery C.A.
        • Stucky C.L.
        Sickle cell mice exhibit mechanical allodynia and enhanced responsiveness in light touch cutaneous mechanoreceptors.
        Mol Pain. 2012; 8: 62
        • Gershon R.C.
        • Rothrock N.
        • Hanrahan R.
        • Bass M.
        • Cella D.
        The use of PROMIS and assessment center to deliver patient-reported outcome measures in clinical research.
        J Appl Meas. 2010; 11: 304-314
        • Gracely R.H.
        • McGrath F.
        • Dubner R.
        Ratio scales of sensory and affective verbal pain descriptors.
        Pain. 1978; 5: 5-18
      2. IASP Taxonomy Working Group: Classification of Chronic Pain, Second Edition (Revised). Classification of chronic pain (pain terms) Available at: https://www.iasp-pain.org/files/Content/ContentFolders/Publications2/ClassificationofChronicPain/Part_III-PainTerms.pdf. Accessed October 19, 2016

        • Hollins M.
        • Stonerock G.L.
        • Kisaalita N.R.
        • Jones S.
        • Orringer E.
        • Gil K.M.
        Detecting the emergence of chronic pain in sickle cell disease.
        J Pain Symptom Manage. 2012; 43: 1082-1093
        • Irwin D.E.
        • Stucky B.
        • Langer M.M.
        • Thissen D.
        • Dewitt E.M.
        • Lai J.S.
        • Varni J.W.
        • Yeatts K.
        • DeWalt D.A.
        An item response analysis of the pediatric PROMIS anxiety and depressive symptoms scales.
        Qual Life Res. 2010; 19: 595-607
        • Irwin D.E.
        • Varni J.W.
        • Yeatts K.
        • DeWalt D.A.
        Cognitive interviewing methodology in the development of a pediatric item bank: A patient reported outcomes measurement information system (PROMIS) study.
        Health Qual Life Outcomes. 2009; 7: 3
        • Jacob E.
        • Chan V.W.
        • Hodge C.
        • Zeltzer L.
        • Zurakowski D.
        • Sethna N.F.
        Sensory and thermal quantitative testing in children with sickle cell disease.
        J Pediatr Hematol Oncol. 2015; 37: 185-189
        • Kenyon N.
        • Wang L.
        • Spornick N.
        • Khaibullina A.
        • Almeida L.E.
        • Cheng Y.
        • Wang J.
        • Guptill V.
        • Finkel J.C.
        • Quezado Z.M.
        Sickle cell disease in mice is associated with sensitization of sensory nerve fibers.
        Exp Biol Med (Maywood). 2015; 240: 87-98
        • Kohli D.R.
        • Li Y.
        • Khasabov S.G.
        • Gupta P.
        • Kehl L.J.
        • Ericson M.E.
        • Nguyen J.
        • Gupta V.
        • Hebbel R.P.
        • Simone D.A.
        • Gupta K.
        Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.
        Blood. 2010; 116: 456-465
        • Lei J.
        • Benson B.
        • Tran H.
        • Ofori-Acquah S.F.
        • Gupta K.
        Comparative analysis of pain behaviours in humanized mouse models of sickle cell anemia.
        PLoS One. 2016; 11: e0160608
        • Levenson J.L.
        • McClish D.K.
        • Dahman B.A.
        • Bovbjerg V.E.
        • de A Citero V.
        • Penberthy L.T.
        • Aisiku I.P.
        • Roberts J.D.
        • Roseff S.D.
        • Smith W.R.
        Depression and anxiety in adults with sickle cell disease: The PiSCES project.
        Psychosom Med. 2008; 70: 192-196
        • Mathur V.A.
        • Kiley K.B.
        • Carroll C.P.
        • Edwards R.R.
        • Lanzkron S.
        • Haythornthwaite J.A.
        • Campbell C.M.
        Disease-related, nondisease-related, and situational catastrophizing in sickle cell disease and its relationship with pain.
        J Pain. 2016; 17: 1227-1236
      3. Medoc: Medoc TSA-II NeuroSensory Analyzer. Available at: http://www.medoc-web.com/products/tsa-ii. Accessed December 23, 2015

        • Myrvik M.P.
        • Burks L.M.
        • Hoffman R.G.
        • Dasgupta M.
        • Panepinto J.A.
        Mental health disorders influence admission rates for pain in children with sickle cell disease.
        Pediatr Blood Cancer. 2013; 60: 1211-1214
        • O’Leary J.D.
        • Crawford M.W.
        • Odame I.
        • Shorten G.D.
        • McGrath P.A.
        Thermal pain and sensory processing in children with sickle cell disease.
        Clin J Pain. 2014; 30: 244-250
        • Panepinto J.A.
        • Pajewski N.M.
        • Foerster L.M.
        • Hoffmann R.G.
        The performance of the PedsQL generic core scales in children with sickle cell disease.
        J Pediatr Hematol Oncol. 2008; 30: 666-673
        • Panepinto J.A.
        • Torres S.
        • Bendo C.B.
        • McCavit T.L.
        • Dinu B.
        • Sherman-Bien S.
        • Bemrich-Stolz C.
        • Varni J.W.
        PedsQL sickle cell disease module: Feasibility, reliability, and validity.
        Pediatr Blood Cancer. 2013; 60: 1338-1344
        • Panepinto J.A.
        • Torres S.
        • Varni J.W.
        Development of the PedsQL Sickle Cell Disease Module items: Qualitative methods.
        Qual Life Res. 2012; 21: 341-357
        • Parkerson H.A.
        • Noel M.
        • Page M.G.
        • Fuss S.
        • Katz J.
        • Asmundson G.J.
        Factorial validity of the English-language version of the Pain Catastrophizing Scale–child version.
        J Pain. 2013; 14: 1383-1389
        • Platt O.S.
        • Thorington B.D.
        • Brambilla D.J.
        • Milner P.F.
        • Rosse W.F.
        • Vichinsky E.
        • Kinney T.R.
        Pain in sickle cell disease. Rates and risk factors.
        N Engl J Med. 1991; 325: 11-16
        • Rolke R.
        • Baron R.
        • Maier C.
        • Tolle T.R.
        • Treede R.D.
        • Beyer A.
        • Binder A.
        • Birbaumer N.
        • Birklein F.
        • Botefur I.C.
        • Braune S.
        • Flor H.
        • Huge V.
        • Klug R.
        • Landwehrmeyer G.B.
        • Magerl W.
        • Maihofner C.
        • Rolko C.
        • Schaub C.
        • Scherens A.
        • Sprenger T.
        • Valet M.
        • Wasserka B.
        Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values.
        Pain. 2006; 123: 231-243
        • Schlenz A.M.
        • Schatz J.
        • McClellan C.B.
        • Roberts C.W.
        Responsiveness of the PedsQL to pain-related changes in health-related quality of life in pediatric sickle cell disease.
        J Pediatr Psychol. 2012; 37: 798-807
        • Schreiber K.L.
        • Martel M.O.
        • Shnol H.
        • Shaffer J.R.
        • Greco C.
        • Viray N.
        • Taylor L.N.
        • McLaughlin M.
        • Brufsky A.
        • Ahrendt G.
        • Bovbjerg D.
        • Edwards R.R.
        • Belfer I.
        Persistent pain in postmastectomy patients: Comparison of psychophysical, medical, surgical, and psychosocial characteristics between patients with and without pain.
        Pain. 2013; 154: 660-668
        • Smith W.R.
        • Penberthy L.T.
        • Bovbjerg V.E.
        • McClish D.K.
        • Roberts J.D.
        • Dahman B.
        • Aisiku I.P.
        • Levenson J.L.
        • Roseff S.D.
        Daily assessment of pain in adults with sickle cell disease.
        Ann Intern Med. 2008; 148: 94-101
        • Sogutlu A.
        • Levenson J.L.
        • McClish D.K.
        • Rosef S.D.
        • Smith W.R.
        Somatic symptom burden in adults with sickle cell disease predicts pain, depression, anxiety, health care utilization, and quality of life: the PiSCES project.
        Psychosomatics. 2011; 52: 272-279
        • Sullivan M.J.
        • Bishop S.R.
        • Pivik J.
        The Pain Catastrophizing Scale: Development and validation.
        Psychol Assess. 1995; 7: 524-532
        • Tsao J.C.
        • Jacob E.
        • Seidman L.C.
        • Lewis M.A.
        • Zeltzer L.K.
        Psychological aspects and hospitalization for pain crises in youth with sickle-cell disease.
        J Health Psychol. 2014; 19: 407-416
        • Van Damme S.
        • Crombez G.
        • Bijttebier P.
        • Goubert L.
        • Van Houdenhove B.
        A confirmatory factor analysis of the Pain Catastrophizing Scale: Invariant factor structure across clinical and non-clinical populations.
        Pain. 2002; 96: 319-324
        • Varni J.W.
        • Burwinkle T.M.
        • Seid M.
        • Skarr D.
        The PedsQL 4.0 as a pediatric population health measure: Feasibility, reliability, and validity.
        Ambul Pediatr. 2003; 3: 329-341
        • Varni J.W.
        • Limbers C.A.
        The PedsQL 4.0 Generic Core Scales Young Adult Version: Feasibility, reliability and validity in a university student population.
        J Health Psychol. 2009; 14: 611-622
        • Varni J.W.
        • Seid M.
        • Knight T.S.
        • Uzark K.
        • Szer I.S.
        The PedsQL 4.0 Generic Core Scales: Sensitivity, responsiveness, and impact on clinical decision-making.
        J Behav Med. 2002; 25: 175-193
        • Varni J.W.
        • Seid M.
        • Rode C.A.
        The PedsQL: Measurement model for the pediatric quality of life inventory.
        Med Care. 1999; 37: 126-139
        • Varni J.W.
        • Stucky B.D.
        • Thissen D.
        • Dewitt E.M.
        • Irwin D.E.
        • Lai J.S.
        • Yeatts K.
        • Dewalt D.A.
        PROMIS Pediatric Pain Interference Scale: An item response theory analysis of the pediatric pain item bank.
        J Pain. 2010; 11: 1109-1119
        • Walker L.S.
        • Beck J.E.
        • Garber J.
        • Lambert W.
        Children’s Somatization Inventory: Psychometric properties of the revised form (CSI-24).
        J Pediatr Psychol. 2009; 34: 430-440
        • Woolf C.J.
        Central sensitization: Implications for the diagnosis and treatment of pain.
        Pain. 2011; 152: S2-S15
        • Zappia K.J.
        • Garrison S.R.
        • Hillery C.A.
        • Stucky C.L.
        Cold hypersensitivity increases with age in mice with sickle cell disease.
        Pain. 2014; 155: 2476-2485